AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2015
Oct 1, 2015
31949_dirs_2015-10-01_50cdbcc2-1264-4508-b134-d1134576a1b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01
Reporting Person: VERNON W ANTHONY (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Buy Ordinary Shares | $0.17 | 2016-12-25 | Ordinary Shares (249085) | Direct |
Footnotes
F1: Fully vested and currently exercisable as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3